PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-68

  1. 1,578 Posts.
    lightbulb Created with Sketch. 165
    Yes, and the fact that it will be more modestly priced
    will help, if no DMOAD. Just hope PR is as good as his
    word and doesn’t trying chasing after DM if we fail
    at it getting it at first try. The sooner we get Zilosul
    to market with or without DM the better.

    As you say Dungiven, it will still have the makings
    of a blockbuster without DM and surely there would
    would be opportunities down the track to apply
    for DM status after reg. approval.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.